Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB081)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB080)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
pan-RAS (on)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB070)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
RIPK1
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB069)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
JAK1 (oral)
—
- Therapy
- Others > Musculoskeletal & Orthopedics
- Status
- Candidate licensing (UB068)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
JAK1 (Gel)
—
- Therapy
- Dermatology
- Status
- Candidate licensing (UB067)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
P2Y12R
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB066)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
P2Y12R
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB065)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
TEAD
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB064)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
HBV Caspid
—
- Therapy
- Gastroenterology & Hepatology
- Status
- Candidate licensing (UB063)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
KCNQ2/3
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB062)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1R; GIPR; GCGR
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB052)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1; GIP
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB051)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GCGR
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB050)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
μ opioid receptor
—
- Therapy
- Gastroenterology & Hepatology
- Status
- Candidate licensing (UB049)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1; GCG
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB048)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1; GCG
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB047)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB046)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB045)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
Microtubule (ADC payload)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB044)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Agmatinase; Imidazoline Rc; NMDA Rc
—
- Therapy
- Others > Psychiatry
- Status
- Candidate licensing (UB043)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- South Korea
Licensing pipeline
5-HT; DA
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB042)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- South Korea
Licensing pipeline
HERV-K Env-TM
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB041)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Multiple targets; immunostimulants
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB040)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TGFβ1; COX-2 (siRNA)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB039)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
TGFβ1; COX-2 (siRNA)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB038)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Nectin-4 x Trop2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB032)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
cMet x HER2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB031)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
cMyc pathway
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB030)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
KV1.3 (Oral)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB029)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, Australia, China
Licensing pipeline
FXIa
—
- Therapy
- Other
- Status
- Candidate licensing (UB028)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
mTORC2 x DDR
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB027)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ATR x mTOR
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB026)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
cMyc
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB025)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
KV1.3 (Topical)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB024)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
PD-L1; VEGF
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB023)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
HER2/Trop2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB022)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PD-1/IL-15 cytokine antibody conjudgate
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB020)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GPC3; CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB019)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
RORI; CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB018)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
IL-12 prodrug
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB017)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
LAG3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB013)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1 R
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB012)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GLP-1 R
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB010)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
‹ PrevPage 18 / 18